Drawing for CLEARMED

USPTO serial 99120055

CLEARMED

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLEARMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962United States

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic test strips for urine analysis; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol and drugs; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs for medical purposesACTIVE
010Multi-drug testing cups for drug use testing purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 30, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 30, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 30, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 4, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2025DOCKASSIGNED TO EXAMINER
Aug 2, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Apr 3, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance